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Abstract. At the end of World War I, British medical officers noted that soldiers infected with malaria were more
likely to die during the 1918 influenza pandemic than those without malaria. This synergistic mortality appeared to be
specific to Plasmodium falciparum and has not been generally noted since 1920. A possible explanation is that a malaria-
induced procoagulant state enhanced the activation of influenza virus to increase inflammation and subsequent severe
clinical outcomes. Falciparum proteins bind and likely inhibit antithrombin 3 and other factors. Pathogens interact in
ways that may inform pathophysiology studies of remote epidemics.
The co-existence of a malarial infection seemed to render
the patient extremely susceptible to this post-influenzal
pneumonia and to lower his chance of recovery from it
almost to vanishing point. (W Angus, Palestine 1919)1
The influenza pandemic of 1918 killed more people than
died during World War I.2 Although influenza pandemics
have reappeared intermittently, the extreme mortality of influ-
enza in 1918–1920 has never been well explained, especially its
unique concentration in young adults from 20 to 40 years of
age.3 During World War I, British Army soldiers were severely
affected by malaria in Palestine (modern Israel/Jordan/Syria),
Macedonia (modernGreece), andMesopotamia (modern Iraq).
When the influenza pandemic arrived at the end of the war,
severe clinical outcomes were observed nearly everywhere,
but some of the highest mortality rates were in soldiers simul-
taneously infected with falciparum malaria. Although limited
by the laboratory resources available in that era, keen clinical
observers detected synergistic mortality between falciparum
malaria and pandemic influenza in all the three countries and
confirmed their findings with postmortem studies.4–6 That the
two pathogens might increase mortality when they simulta-
neously infected the same person was not surprising, but the
independently reported mortality of dually infected soldiers
was so great as to raise questions regarding the pathophysiol-
ogy especially because this effect has not been observed since
1920. Insight may be obtained by constructing plausible sce-
narios based on modern understanding of infection and
inflammation specifically Plasmodium falciparum’s effect on
the coagulation cascade. An interaction between parasite and
viral proteins is hypothesized to be a likely explanation of
synergistic mortality during the influenza pandemic of 1918.
The increased mortality of combined influenza and malaria
infections was spontaneously noted by the medical officers in
1918 despite the very different military and public health
situations in Palestine, Macedonia, and Mesopotamia.4–6
Postmortem studies in Palestine by Fairley showed 59% of
80 malaria deaths complicated by influenza, in Egypt Manson-
Bahr observed 48% of 67 malaria deaths complicated by influ-
enza and in Macedonia out of 100 deaths due to influenza, 83%
also had malaria infection.4–6 The massive number of casualties
occurring during the influenza pandemic precluded detailed
public health observations from this unanticipated disaster as
all medical units were operating far beyond capacity in
addition to having many ill staff members.7 One demonstration
of influenza’s synergistic mortality with malaria comes from
Macedonia, where in 1918, although the total number of
malaria cases decreased, the malaria-attributed mortality
increased markedly at the time of the influenza pandemic
(the case fatality rate rose, see Figure 1 in reference 8).
The East African campaign had the highest malaria rates
in the British Army (599/1000 hospitalized in 1918) during
World War I.9,10 Estimates of the influenza-associated mor-
tality in British and South African troops (56/1000) are much
higher than in Indian and African soldiers (15/1000) using
Commonwealth War Graves Commission mortality figures
with mean troop strength as a denominator.9,10 This is suggestive
that those soldiers more likely to have acute malaria because
of lack of immunity also had higher influenza-associated mor-
tality. Equivalent mortality rates from the much less malari-
ous Mesopotamian campaign were 9/1000 in British soldiers
and 14/1000 in Indian soldiers.
The mechanism of any synergistic mortality effect between
influenza and malaria is unknown, and may simply reflect addi-
tive mortality of two serious infectious diseases. Although all
soldiers in East Africa were likely to have been infected with
malaria at some time during 1918, Indian and African soldiers
were more likely than British and South African soldiers to
have had a history of previous infections. Attempts to find cor-
relations between influenza mortality and malaria endemicity
by district using prospectively collected civilian monthly mor-
tality reports and historical malaria maps from colonial India
were unsuccessful indicating either that there were no such
relationships or any putative effect could not be distinguished
from a background of chronic malaria infection (Katherine
Battle and Siddharth Chandra, personal communication).
Modern investigations have suggested possible mechanisms
to explain mortality synergy with influenza and malaria.
Falciparum malaria commonly causes a procoagulant state
although rarely does it progress to clinical bleeding. Although
the exact nature of the coagulation disturbance is unclear, it is
possibly due to interactions between the parasite histidine-
rich protein 2 (HRP2) and elements of the coagulation cas-
cade.11 HRP2 is a highly positively charged protein excreted
in large quantities into the plasma, which binds to negatively
charged heparin as well as antithrombin 3. The binding of
HRP2 to heparin occurs at nanomolar concentrations and is
dependent on zinc ions.11 Inhibition of the anticoagulant
heparin increases tendency toward coagulation just as does
the inhibition of antithrombin 3.
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Disturbances of coagulation and fibrinolysis may modify
inflammatory reactions to influenza. Plasmin and fibrin are
activated serine proteases that increase during influenza possi-
bly activating viral hemagglutinin, and serve as markers of
inflammation.12 It is known that the viral hemagglutinin binds
plasminogen which may have a role in its activation and infec-
tion of pulmonary cells.13 A molecular mechanism explaining
synergistic mortality during simultaneous malaria and influ-
enza infections therefore may be the cooperative interaction
of parasite and host proteins, which may exaggerate pulmonary
infection and inflammation.12 Such inflammation may have
increased pulmonary failure or led to ineffective host response
to secondary bacterial pneumonias that appear to have been
the proximate cause of death of most victims of the 1918 influ-
enza pandemic.14 Synergistic mortality studies during epi-
demics involve intrinsically difficult measurements. No similar
observations have been reported since 1918 suggesting either
that the unique mortality pattern of the 1918 pandemic
extended to its interaction with malaria or that subsequently
improved therapeutic means such as antibiotics and antimalar-
ial drugs obscured any synergism. Although it has been possi-
ble to reconstruct the influenza virus of 1918 from archived
pathology specimens, no such materials exist to inform patho-
gen interaction studies.3 It may still be possible to use the
clinical observations of military medical officers of World War
I to better understand the lethality of the 1918 pandemic espe-
cially as it relates to dual infections with falciparum malaria.
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